In Safety warnings, alerts and recalls

Enter a keyword or phrase to search all pages in this section:


Advanced search

Archive:

Looking for a previously published document in this section?

Safety of selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs)

24 October 2006

The Commission on Human Medicines (CHM) has written to healthcare professionals informing them that non-steroidal anti-inflammatory drugs (NSAIDs) may be associated with a small risk of arterial thrombotic events, such as heart attack or stroke, when used in high doses and for long-term treatment.

Following a European review into the safety of NSAIDs, we will ask industry to update product information for NSAIDs based on recommendations by the CHM and the scientific opinion of the Committee for Medicinal Products for Human Use (CHMP).

The European Medicines Agency (EMEA) has issued the following press release:
› European Medicines Agency review concludes positive benefit-risk balance for non-selective NSAIDs (external link)

Page last modified: 24 October 2006